Clinical Outcomes for Cancer Patients with Bacteremia in Peru, 2020-2024

Peruvian cancer patients with bloodstream infections at a referral center in Lima. The dataset contains 293 patient records from July 2020 to June 2024, with a 28-day all-cause mortality rate of 32.1%. It was authored by Yosué Vera and shared under a CC-BY-4.0 license.

Use Cases

• Predicting 28-day mortality risk based on factors like sepsis, septic shock, and comorbidities mentioned in the description.
• Analyzing the association between specific pathogens (e.g., ESBL-producing Enterobacteriaceae) and patient outcomes.
• Modeling the impact of appropriate empirical antimicrobial therapy on survival rates in cancer patients.
• Investigating demographic and clinical factors (e.g., Charlson Comorbidity Index, tumor type) linked to bacteremia mortality.

Strengths

• Contains 293 patient records with a defined 28-day mortality outcome.
• Includes specific, reported statistics such as a 32.1% mortality rate and an 80.7% rate of appropriate empirical therapy.
• Covers a four-year time range from July 2020 to June 2024.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data reflects a single referral center in Lima, Peru, which may limit generalizability.

Provenance

Source

figshare, authored by Yosué Vera.

Collection Method

Retrospective analysis of first episodes of bacteremia in hospitalized adult cancer patients.

Time Range

July 2020 to June 2024.

Freshness

Last updated 2026-05-22 17:43:18; freshness should be verified.

Geography

A referral cancer center in Lima, Peru.